← back to search

Sander Florman

Mount Sinai Hospital · US
Area of research
Hepatology · Surgery
Research interest
Research interests include Organ Transplantation Techniques and Outcomes, Renal Transplantation Outcomes and Treatments, Liver Disease and Transplantation, and Hepatocellular Carcinoma Treatment and Prognosis.
h-index
54
citations
11,181
works
359
NIH funding
primary concept
Medicine
email

Recent publications

Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With HIV in the United States.
2026cited by 4position: contributordoi
Increased rate of deceased donor liver transplantation for candidates willing to receive organs from donors with human immunodeficiency virus
American Journal of Transplantation 2026cited by 2position: contributordoi
Ex Situ Abdominal Multivisceral Normothermic Machine Perfusion: A Research Protocol.
2026cited by 0position: contributordoi
Allograft Rejection and the Latent HIV Reservoir in Kidney Transplant Recipients with HIV.
2026cited by 0position: contributordoi
Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study
Journal of Hepatology 2025cited by 64position: contributordoi
Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort study
Hepatology 2025cited by 17position: middledoi
Kaposi Sarcoma–Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With HIV in the United States
Clinical Infectious Diseases 2025cited by 8position: middledoi
Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort study.
2025cited by 7position: contributordoi
Liver Transplant for Upfront Unresectable Colorectal Metastases
JAMA Surgery 2025cited by 4position: middledoi
Breaking barriers: Successful outcomes of hepatitis C virus D+/R− transplants in HIV+ recipients
American Journal of Transplantation 2025cited by 4position: contributordoi
HIV Superinfection in Kidney Transplant Recipients With HIV Who Received Organs From Donors With HIV.
2025cited by 2position: contributordoi
<i>APOL1</i> genotype and patient outcomes in US and South African transplant recipients with HIV who received kidneys from donors with HIV
2025cited by 2position: contributordoi
Normothermic machine perfusion of explanted livers: Exploratory study of an alternative translational model for end-stage liver disease.
2025cited by 1position: contributordoi
Initial Efforts to Stratify Patients and Donors Utilizing Normothermic Machine Preservation of Livers for Transplant.
2025cited by 1position: contributordoi
Jehovah's Witnesses: Challenges in liver disease management and in liver transplantation.
2025cited by 0position: contributordoi
An Iterative Design Approach to Development of an Ex Situ Normothermic Multivisceral Perfusion Platform.
2025cited by 0position: contributordoi
Treating Donation After Circulatory Death Liver Grafts With Alteplase During Ex Situ Normothermic Machine Perfusion.
2025cited by 0position: contributordoi
Intracardiac thrombosis and its management during liver transplantation: international, multicenter, case-control study.
2025cited by 0position: contributordoi
Improved Outcomes of Liver Transplant Recipients Discharged to a Dedicated Inpatient Rehabilitation Facility
Journal of Scientific Innovation in Medicine 2025cited by 0position: contributordoi
Secondary Perfusion to Model Viability of Livers Declined for Transplantation
Livers 2025cited by 0position: contributordoi
Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study
Journal of Hepatology 2024cited by 69position: middledoi
Safety of Kidney Transplantation from Donors with HIV
New England Journal of Medicine 2024cited by 48position: middledoi
Impact of race-neutral eGFR calculations on African American kidney transplant candidate wait time: A single center retrospective analysis.
2024cited by 7position: contributordoi
The potential of machine learning to predict early allograft dysfunction after normothermic machine perfusion in liver transplantation.
2024cited by 4position: contributordoi
Asystolic donor warm ischemia time is associated with development of postreperfusion syndrome in donation after circulatory death liver transplant.
2024cited by 3position: contributordoi
Outcomes after kidney transplant alone in patients with cirrhosis-A case-control study.
2024cited by 1position: contributordoi
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium
Liver Transplantation 2023cited by 43position: middledoi
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium.
2023cited by 33position: contributordoi
Wait Time Advantage for Transplant Candidates With HIV Who Accept Kidneys From Donors With HIV Under the HOPE Act
Transplantation 2023cited by 30position: middledoi
Downstaging hepatocellular carcinoma before liver transplantation: A multicenter analysis of the “all-comers” protocol in the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) consortium
American Journal of Transplantation 2023cited by 21position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 39 papers (2019–2026)Parissa Tabrizian · University Health Network11 papers (2018–2025)Christine M. Durand · National Institute of Allergy and Infectious Diseases10 papers (2018–2026)Neil Mehta · Institute for Biotechnology and Bioengineering8 papers (2021–2025)Leona Kim‐Schluger · Mount Sinai Hospital8 papers (2024–2026)Aaron A.R. Tobian · Weatherford College7 papers (2018–2026)Francis Y. Yao · University of California, San Francisco7 papers (2021–2025) · 6 papers (2022–2026) · 6 papers (2022–2026)L. Leonie van Leeuwen · Mount Sinai Hospital6 papers (2024–2026)Allan B. Massie · NYU Langone Health5 papers (2018–2026)Antonios Arvelakis · 5 papers (2019–2025)Nahel Elias · Harvard University5 papers (2022–2026)Andrew Santeusanio · The Mount Sinai Hospital5 papers (2020–2021) · 5 papers (2022–2025)Maarouf Hoteit · University of California, Los Angeles4 papers (2021–2025)Dorry L. Segev · National Institute of Allergy and Infectious Diseases4 papers (2018–2020)Alexander Gilbert · Georgetown University4 papers (2022–2026)Valentina Stosor · National Institute of Allergy and Infectious Diseases4 papers (2022–2026)Dorry L. Segev · New York University4 papers (2025–2026)